Welcome to LookChem.com Sign In|Join Free
  • or
Betulonic acid, a naturally occurring triterpenoid compound, is derived from various plant sources, including the Betula genus. It exhibits a range of biological activities and possesses potential therapeutic properties due to its unique chemical structure.

4481-62-3

Post Buying Request

4481-62-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

4481-62-3 Usage

Uses

Used in Pharmaceutical Industry:
Betulonic acid is used as a cytotoxic agent for its potent activities against various cancer cell lines, such as PC3, MGC-803, Bcap-37, and MCF-7. This makes it a promising candidate for the development of novel anticancer drugs and therapies.
Additionally, Betulonic acid can be further explored for its potential applications in other industries, such as cosmetics or agriculture, where its biological activities may provide benefits. However, more research would be required to determine its suitability and efficacy in these areas.

Check Digit Verification of cas no

The CAS Registry Mumber 4481-62-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,4,8 and 1 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 4481-62:
(6*4)+(5*4)+(4*8)+(3*1)+(2*6)+(1*2)=93
93 % 10 = 3
So 4481-62-3 is a valid CAS Registry Number.
InChI:InChI=1/C30H46O3/c1-18(2)19-10-15-30(25(32)33)17-16-28(6)20(24(19)30)8-9-22-27(5)13-12-23(31)26(3,4)21(27)11-14-29(22,28)7/h19-22,24H,1,8-17H2,2-7H3,(H,32,33)/t19-,20+,21-,22+,24+,27-,28+,29+,30-/m0/s1

4481-62-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name Betulonicacid

1.2 Other means of identification

Product number -
Other names Betulonic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:4481-62-3 SDS

4481-62-3Synthetic route

betulonic aldehyde
4439-98-9

betulonic aldehyde

betulonic acid
4481-62-3

betulonic acid

Conditions
ConditionsYield
With sodium chlorite; sodium dihydrogen phosphate monohydrate; 2-methyl-but-2-ene In water; tert-butyl alcohol at 20℃; for 2h; Inert atmosphere;100%
With sodium chlorite; sodium dihydrogen phosphate monohydrate; 2-methyl-but-2-ene In water; tert-butyl alcohol at 20℃; for 2h;100%
With sodium chlorite; sodium dihydrogen phosphate monohydrate; 2-methyl-but-2-ene In water; tert-butyl alcohol at 20℃; for 2h; Inert atmosphere;100%
cyclohexylammonium betulonate

cyclohexylammonium betulonate

betulonic acid
4481-62-3

betulonic acid

Conditions
ConditionsYield
With phosphoric acid In dichloromethane; water96%
Betulinic acid
472-15-1

Betulinic acid

betulonic acid
4481-62-3

betulonic acid

Conditions
ConditionsYield
With pyridinium chlorochromate In chloroform for 2h; Ambient temperature;93%
With Jones reagent In dichloromethane; acetone at 20℃; for 0.25h; Cooling;93%
With Jones reagent In dichloromethane; acetone at 20℃; Cooling;93%
betulin
473-98-3

betulin

betulonic acid
4481-62-3

betulonic acid

Conditions
ConditionsYield
Stage #1: betulin In acetone at 40℃; for 0.5h;
Stage #2: With Jones reagent at -10℃; for 4h; Solvent;
87.6%
With Jones reagent81.8%
With Jones reagent at 25℃; for 4h; Jones Oxidation;81%
betulin
473-98-3

betulin

A

betulonic aldehyde
4439-98-9

betulonic aldehyde

B

betulonic acid
4481-62-3

betulonic acid

Conditions
ConditionsYield
With Jones reagent In acetone at 0℃; for 2.25h;A 6%
B 86%
With Jones reagent In acetone at 0 - 20℃; for 3h; Inert atmosphere;A 6%
B 86%
With Jones reagent In acetone at 0 - 20℃; Inert atmosphere;A n/a
B 57%
betulin
473-98-3

betulin

A

betulonic aldehyde
4439-98-9

betulonic aldehyde

B

betulinic aldehyde
13159-28-9, 92594-07-5

betulinic aldehyde

C

Betulinic acid
472-15-1

Betulinic acid

D

betulonic acid
4481-62-3

betulonic acid

Conditions
ConditionsYield
With dipyridinium dichromate In water; N,N-dimethyl-formamideA 20%
B 7%
C 8%
D 13%
betulin
473-98-3

betulin

acetic acid
64-19-7

acetic acid

CrO3

CrO3

A

betulonic aldehyde
4439-98-9

betulonic aldehyde

B

betulonic acid
4481-62-3

betulonic acid

C

acid C30H46O3

acid C30H46O3

Conditions
ConditionsYield
at 2℃;
pyridine
110-86-1

pyridine

betulonic aldehyde
4439-98-9

betulonic aldehyde

KMnO4

KMnO4

betulonic acid
4481-62-3

betulonic acid

betulone
7020-34-0

betulone

betulonic acid
4481-62-3

betulonic acid

Conditions
ConditionsYield
With sodium chlorite; sodium dihydrogenphosphate; dihydrogen peroxide In water; acetonitrile at 20℃;347 mg
With Jones reagent
betulin diacetate
1721-69-3

betulin diacetate

betulonic acid
4481-62-3

betulonic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: NaOH / methanol; tetrahydrofuran / 168000 h / 20 °C
2: 4.8 g / Jones reagent / acetone / 7 h / 0 °C
View Scheme
betulonic aldehyde
4439-98-9

betulonic aldehyde

betulinic aldehyde
13159-28-9, 92594-07-5

betulinic aldehyde

A

Betulinic acid
472-15-1

Betulinic acid

B

betulonic acid
4481-62-3

betulonic acid

Conditions
ConditionsYield
Stage #1: betulonic aldehyde; betulinic aldehyde With sodium chlorite; sodium dihydrogenphosphate; 2-methyl-but-2-ene In water; tert-butyl alcohol at 20℃; for 18.5h; Inert atmosphere;
Stage #2: With sodium hydroxide In water; tert-butyl alcohol at 20℃; for 1.5h;
Stage #3: With hydrogenchloride In water for 2.5h; Overall yield = 17.8 g;
(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13bR)-3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-1H-cyclopenta[a]chrysen-9-ol
1072913-62-2

(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13bR)-3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-1H-cyclopenta[a]chrysen-9-ol

betulonic acid
4481-62-3

betulonic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: triethylamine; oxalyl dichloride; dimethyl sulfoxide / dichloromethane / 0.42 h / -15 °C / Inert atmosphere
2: 2-methyl-but-2-ene; sodium chlorite; sodium dihydrogen phosphate monohydrate / water; tert-butyl alcohol / 2 h / 20 °C / Inert atmosphere
View Scheme
betulonic aldehyde
4439-98-9

betulonic aldehyde

A

28-norlup-20(29)-en-3-one-17β-hydroperoxide

28-norlup-20(29)-en-3-one-17β-hydroperoxide

B

28-norlup-20(29)-en-3-one-17α-hydroperoxide

28-norlup-20(29)-en-3-one-17α-hydroperoxide

C

betulonic acid
4481-62-3

betulonic acid

Conditions
ConditionsYield
With air In acetone at 20℃; for 336h;A 57.7 mg
B 32.9 mg
C 176.4 mg
betulin
473-98-3

betulin

A

betulonic aldehyde
4439-98-9

betulonic aldehyde

B

betulinic aldehyde
13159-28-9, 92594-07-5

betulinic aldehyde

C

betulonic acid
4481-62-3

betulonic acid

Conditions
ConditionsYield
With Ru/C; air In 1,3,5-trimethyl-benzene at 140℃; for 6h; Overall yield = 48 %;
betulonic acid
4481-62-3

betulonic acid

betulonic acid chloride
150841-01-3

betulonic acid chloride

Conditions
ConditionsYield
With oxalyl dichloride In dichloromethane at 20℃; for 6h; Inert atmosphere;99%
With oxalyl dichloride In benzene95%
With oxalyl dichloride In dichloromethane at 20℃; for 6h;89%
betulonic acid
4481-62-3

betulonic acid

methyl betulonate
4356-31-4

methyl betulonate

Conditions
ConditionsYield
In diethyl ether98%
With diethyl ether
Esterification;
betulonic acid
4481-62-3

betulonic acid

3-oxolupan-28-ic acid
25576-27-6

3-oxolupan-28-ic acid

Conditions
ConditionsYield
With palladium 10% on activated carbon; hydrogen In tetrahydrofuran; methanol at 20℃; for 22h;98%
With palladium 10% on activated carbon; hydrogen In tetrahydrofuran; methanol at 23℃; under 760.051 Torr; for 12h;94%
With palladium on activated charcoal; hydrogen In tetrahydrofuran; methanol at 20℃;94%
betulonic acid
4481-62-3

betulonic acid

methyl iodide
74-88-4

methyl iodide

methyl betulonate
4356-31-4

methyl betulonate

Conditions
ConditionsYield
With potassium carbonate In acetone at 20℃;98%
With potassium carbonate In acetone at 25℃; for 24h;94%
With potassium carbonate In N,N-dimethyl-formamide at 23 - 40℃; for 5h; Inert atmosphere;90%
betulonic acid
4481-62-3

betulonic acid

2-hydroxy-3-oxo-lupa-1,20(29)-dien-28-oic acid
173106-22-4

2-hydroxy-3-oxo-lupa-1,20(29)-dien-28-oic acid

Conditions
ConditionsYield
With potassium tert-butylate In tetrahydrofuran; tert-butyl alcohol at 50℃; for 3h;97%
With potassium tert-butylate; oxygen In tert-butyl alcohol at 400℃; for 0.666667h;82%
With air; potassium tert-butylate In tert-butyl alcohol at 40℃; for 0.666667h;75%
betulonic acid
4481-62-3

betulonic acid

Betulinic acid
472-15-1

Betulinic acid

Conditions
ConditionsYield
Stage #1: betulonic acid With aluminum isopropoxide; benzyl alcohol In tetrahydrofuran at 65℃; for 2h;
Stage #2: With sodium hydroxide In water; xylene at 130℃; for 1h;
Stage #3: With acetic acid In water Conversion of starting material;
96.3%
Stage #1: betulonic acid With aluminum isopropoxide; benzyl alcohol In tetrahydrofuran at 65℃; for 2h; Heating / reflux;
Stage #2: With sodium hydroxide; water In xylenes at 130℃; for 1h;
Stage #3: With acetic acid In water
96.3%
With sodium tetrahydroborate; isopropyl alcohol; sodium hydroxide In water for 3h;94%
betulonic acid
4481-62-3

betulonic acid

propargyl bromide
106-96-7

propargyl bromide

C28-propargylbetulonate

C28-propargylbetulonate

Conditions
ConditionsYield
With potassium carbonate In acetone at 50℃;96%
With potassium carbonate; potassium iodide at 20℃;82%
With potassium carbonate In acetone for 6h; Reflux;74%
With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 1h;
betulonic acid
4481-62-3

betulonic acid

3-Oxo-18α-oleanan-28<*>19β-olide
24099-81-8

3-Oxo-18α-oleanan-28<*>19β-olide

Conditions
ConditionsYield
With sodium carbonate; trifluoroacetic acid In chloroform for 0.133333h;95%
With toluene-4-sulfonic acid In chloroform; water for 3h; Reflux;19%
With formic acid at 100℃;
With formic acid
betulonic acid
4481-62-3

betulonic acid

mercaptoacetic acid
68-11-1

mercaptoacetic acid

3,3-bis[(carboxymethyl)thio]lup-20(29)-en-28-oic acid

3,3-bis[(carboxymethyl)thio]lup-20(29)-en-28-oic acid

Conditions
ConditionsYield
In chloroform at 20℃; for 48h; Dean-Stark;95%
betulonic acid
4481-62-3

betulonic acid

(1R,3aS,5aR,5bR,11aR,E)-9-(hydroxyimino)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-1H-cyclopenta[a]chrysene-3a-carboxylic acid

(1R,3aS,5aR,5bR,11aR,E)-9-(hydroxyimino)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-1H-cyclopenta[a]chrysene-3a-carboxylic acid

Conditions
ConditionsYield
With pyridine; hydroxylamine hydrochloride at 120℃; for 4h; Microwave irradiation;94%
With pyridine; hydroxylamine hydrochloride In ethanol for 72h; Inert atmosphere;87%
With hydroxylamine; sodium acetate In ethanol
betulonic acid
4481-62-3

betulonic acid

3-nitro-benzaldehyde
99-61-6

3-nitro-benzaldehyde

2-(3-nitrobenzylidene)betulonic acid

2-(3-nitrobenzylidene)betulonic acid

Conditions
ConditionsYield
Stage #1: betulonic acid With sodium hydride In tetrahydrofuran at 0℃; for 0.166667h;
Stage #2: 3-nitro-benzaldehyde In tetrahydrofuran at 0 - 20℃; for 1.5h;
93%
betulonic acid
4481-62-3

betulonic acid

4-nitrobenzaldehdye
555-16-8

4-nitrobenzaldehdye

2-(4-nitrobenzylidene)betulonic acid

2-(4-nitrobenzylidene)betulonic acid

Conditions
ConditionsYield
Stage #1: betulonic acid With sodium hydride In tetrahydrofuran at 0℃; for 0.166667h;
Stage #2: 4-nitrobenzaldehdye In tetrahydrofuran at 0 - 20℃; for 1.5h;
93%
betulonic acid
4481-62-3

betulonic acid

(1R,3aS,5aR,5bR,7aR,11aR,11bR,13aR,13bR)-3a-isocyanato-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)octadecahydro-1H-cyclopenta[a]chrysen-9(5bH)-one
628308-21-4

(1R,3aS,5aR,5bR,7aR,11aR,11bR,13aR,13bR)-3a-isocyanato-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)octadecahydro-1H-cyclopenta[a]chrysen-9(5bH)-one

Conditions
ConditionsYield
With diphenyl phosphoryl azide; N-ethyl-N,N-diisopropylamine In 1,4-dioxane at 20 - 102℃; for 16.66h; Concentration; Reagent/catalyst; Temperature; Time; Inert atmosphere;92%
With diphenyl phosphoryl azide; triethylamine In 1,4-dioxane for 18.5h; Reflux;63.2%
With diphenyl phosphoryl azide; triethylamine In 1,4-dioxane for 18.5h; Reflux; Inert atmosphere;63.2%
Multi-step reaction with 2 steps
1: oxalyl chloride / benzene / 2 h / 20 - 22 °C
2: 0.38 g / NaN3 / acetone / 6 h / 20 °C
View Scheme
Multi-step reaction with 2 steps
1: 95 percent / oxalyl chloride / benzene
2: NaN3 / acetone / 6 h / 20 - 22 °C
View Scheme
betulonic acid
4481-62-3

betulonic acid

2,6-dichlorobenzaldehyde
83-38-5

2,6-dichlorobenzaldehyde

2-(2,6-dichlorobenzylidene)betulonic acid

2-(2,6-dichlorobenzylidene)betulonic acid

Conditions
ConditionsYield
Stage #1: betulonic acid With sodium hydride In tetrahydrofuran at 0℃; for 0.166667h;
Stage #2: 2,6-dichlorobenzaldehyde In tetrahydrofuran at 0 - 20℃; for 2h;
92%
5-bromo-2-furancarboxaldehyde
1899-24-7

5-bromo-2-furancarboxaldehyde

betulonic acid
4481-62-3

betulonic acid

2-{(5-bromofuran-2-yl)methylene}betulonic acid

2-{(5-bromofuran-2-yl)methylene}betulonic acid

Conditions
ConditionsYield
Stage #1: betulonic acid With sodium hydride In tetrahydrofuran at 0℃; for 0.166667h;
Stage #2: 5-bromo-2-furancarboxaldehyde In tetrahydrofuran at 0 - 20℃; for 1.7h;
92%
betulonic acid
4481-62-3

betulonic acid

5-bromo-2-methoxybenzaldehyde
25016-01-7

5-bromo-2-methoxybenzaldehyde

2-(5-bromo-2-methoxybenzylidene)betulonic acid

2-(5-bromo-2-methoxybenzylidene)betulonic acid

Conditions
ConditionsYield
Stage #1: betulonic acid With sodium hydride In tetrahydrofuran at 0℃; for 0.166667h;
Stage #2: 5-bromo-2-methoxybenzaldehyde In tetrahydrofuran at 0 - 20℃; for 2h;
92%
4-nitrophenyl azide
1516-60-5

4-nitrophenyl azide

betulonic acid
4481-62-3

betulonic acid

benzylamine
100-46-9

benzylamine

1′-benzyl-1H′-lup-2-eno-[2,3-d][1,2,3]-triazole-28-oic acid

1′-benzyl-1H′-lup-2-eno-[2,3-d][1,2,3]-triazole-28-oic acid

Conditions
ConditionsYield
In toluene at 100℃; for 24h; Molecular sieve;92%
3,5-dimethoxybenzylamine
34967-24-3

3,5-dimethoxybenzylamine

4-nitrophenyl azide
1516-60-5

4-nitrophenyl azide

betulonic acid
4481-62-3

betulonic acid

1′-(3,5-dimethoxybenzyl)-1H′-lup-2-eno-[2,3-d][1,2,3]-triazole-28-oic acid

1′-(3,5-dimethoxybenzyl)-1H′-lup-2-eno-[2,3-d][1,2,3]-triazole-28-oic acid

Conditions
ConditionsYield
In toluene at 100℃; for 24h; Molecular sieve;92%
betulonic acid
4481-62-3

betulonic acid

4-bromo-benzaldehyde
1122-91-4

4-bromo-benzaldehyde

2-(4-bromobenzylidene)betulonic acid

2-(4-bromobenzylidene)betulonic acid

Conditions
ConditionsYield
Stage #1: betulonic acid With sodium hydride In tetrahydrofuran at 0℃; for 0.166667h;
Stage #2: 4-bromo-benzaldehyde In tetrahydrofuran at 0 - 20℃; for 2h;
91%
m-bromobenzoic aldehyde
3132-99-8

m-bromobenzoic aldehyde

betulonic acid
4481-62-3

betulonic acid

2-(3-bromobenzylidene)betulonic acid

2-(3-bromobenzylidene)betulonic acid

Conditions
ConditionsYield
Stage #1: betulonic acid With sodium hydride In tetrahydrofuran at 0℃; for 0.166667h;
Stage #2: m-bromobenzoic aldehyde In tetrahydrofuran at 0 - 20℃; for 1.5h;
91%
betulonic acid
4481-62-3

betulonic acid

ortho-bromobenzaldehyde
6630-33-7

ortho-bromobenzaldehyde

2-(2-bromobenzylidene)betulonic acid

2-(2-bromobenzylidene)betulonic acid

Conditions
ConditionsYield
Stage #1: betulonic acid With sodium hydride In tetrahydrofuran at 0℃; for 0.166667h;
Stage #2: ortho-bromobenzaldehyde In tetrahydrofuran at 0 - 20℃; for 2h;
91%
betulonic acid
4481-62-3

betulonic acid

1-naphthaldehyde
66-77-3

1-naphthaldehyde

2-(naphthalene-1-ylmethylene)betulonic acid

2-(naphthalene-1-ylmethylene)betulonic acid

Conditions
ConditionsYield
Stage #1: betulonic acid With sodium hydride In tetrahydrofuran at 0℃; for 0.166667h;
Stage #2: 1-naphthaldehyde In tetrahydrofuran at 0 - 20℃; for 2h;
91%
betulonic acid
4481-62-3

betulonic acid

3-(hydroxyimino)lup-20(29)-en-28-oic acid
38301-42-7

3-(hydroxyimino)lup-20(29)-en-28-oic acid

Conditions
ConditionsYield
With hydroxylamine hydrochloride In pyridine for 2h; Heating;90%
With pyridine; hydroxylamine hydrochloride In methanol for 16h; Reflux;84%
With pyridine; hydroxylamine hydrochloride at 20℃;72.4%
betulonic acid
4481-62-3

betulonic acid

benzyl chloride
100-44-7

benzyl chloride

benzyl (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-oxo-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-3aH-cyclopenta[a]chrysene-3a-carboxylate
203576-71-0

benzyl (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-oxo-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-3aH-cyclopenta[a]chrysene-3a-carboxylate

Conditions
ConditionsYield
With potassium carbonate for 2h; Reflux;90%
3-thiophene carboxaldehyde
498-62-4

3-thiophene carboxaldehyde

betulonic acid
4481-62-3

betulonic acid

2-(thiophen-3-ylmethylene)betulonic acid

2-(thiophen-3-ylmethylene)betulonic acid

Conditions
ConditionsYield
Stage #1: betulonic acid With sodium hydride In tetrahydrofuran at 0℃; for 0.166667h;
Stage #2: 3-thiophene carboxaldehyde In tetrahydrofuran at 0 - 20℃; for 1h;
90%
3-pyridinecarboxaldehyde
500-22-1

3-pyridinecarboxaldehyde

betulonic acid
4481-62-3

betulonic acid

2-(pyridin-3-ylmethylene)betulonic acid

2-(pyridin-3-ylmethylene)betulonic acid

Conditions
ConditionsYield
Stage #1: betulonic acid With sodium hydride In tetrahydrofuran at 0℃; for 0.166667h;
Stage #2: 3-pyridinecarboxaldehyde In tetrahydrofuran at 0 - 20℃; for 2h;
90%
betulonic acid
4481-62-3

betulonic acid

3-bromo-4-fluorobenzaldehyde
77771-02-9

3-bromo-4-fluorobenzaldehyde

2-(3-bromo-4-fluorobenzylidene)betulonic acid

2-(3-bromo-4-fluorobenzylidene)betulonic acid

Conditions
ConditionsYield
Stage #1: betulonic acid With sodium hydride In tetrahydrofuran at 0℃; for 0.166667h;
Stage #2: 3-bromo-4-fluorobenzaldehyde In tetrahydrofuran at 0 - 20℃; for 1.5h;
90%

4481-62-3Relevant academic research and scientific papers

A convergent synthesis of novel alkyne–azide cycloaddition congeners of betulinic acid as potent cytotoxic agent

Dangroo, Nisar A.,Singh, Jasvinder,Rath, Santosh K.,Gupta, Nidhi,Qayum, Arem,Singh, Shashank,Sangwan, Payare L.

, p. 1 - 12 (2017)

In an endeavour to develop potent anti-tumor agents from betulinic acid (BA), a series of C-28 derived 1,2,3-triazolyl derivatives were designed and synthesized by employing Cu(I) catalyzed Huisgen 1,3-dipolar cycloaddition reaction. All the derivatives were evaluated for cytotoxic activity by MTT assay against five different human cancer cell lines: lung (A549), colon (HCT116), prostate (PC3), pancreatic (MIA PaCa-2) and breast (T47D). The data revealed that compounds 11c, 11d, 11g, 11h and 13a possess most promising cytotoxic potential. The compound 11h was one of the most active compounds, with IC50 values in the range of 4–6?μM against all the five cancer cell lines. The results of this study suggested that derivatives with free –OH (11c, 11d and 11g) and free –COOH (11h and 13a) substitutions in the triazole moiety introduced at the C-28 position significantly improved the anti-tumor activity and may be the favourable position to synthesize potent anticancer leads from BA. Introduction of a non polar alkyl groups at C-28 position (10, 12 and 14) resulted in the significant loss of the activity. Further, DAPI staining, ROS generation and wound healing experiments revealed that compound 11h induces apoptosis in HCT-116 cells.

Autoxidation Products of Betulonaldehyde

Ayers, Sloan,Benkovics, Tamas,Marshall, Jonathan,Tan, Yichen,Strotman, Neil A.,Kiau, Susanne

, p. 2758 - 2761 (2016)

Three major degradation products resulted from the exposure of betulonaldehyde (1) to air in solution at room temperature. From HRMS and NMR data, the products, which were isolated by preparative supercritical fluid chromatography (SFC), were identified a

Synthesis of novel lupane triterpenoid-indazolone hybrids with oxime ester linkage

Khlebnicova, Tatyana S.,Shishkina, Svetlana V.,Zicāne, Daina,Piven, Yuri A.,Tetere, Zenta,Baranovsky, Alexander V.,Rāvi?a, Irisa,Lakhvich, Fedor A.,Kumpi??, Viktors,Rijkure, Inese,Mieri?a, Inese,Peipi??, Uldis,Turks, Māris

, p. 77 - 89 (2017)

An efficient protocol for the synthesis of novel lupane triterpenoid-indazolone hybrids with oxime ester linkage has been developed from naturally accessible precursor betulin. For the first time a series of betulonic acid-indazolone hybrids have been synthesized via an acylation of corresponding 6,7-dihydro-1H-indazol-4(5H)-one oximes with betulonic acid chloride. Diastereoselective reduction of the obtained betulonic acid conjugates with NaBH4resulted in a formation of betulinic acid-indazolone hybrids in excellent yields. The configuration of the key compounds has been fully established by X-ray and 2D NMR analysis.

Synthesis of heterocycle-modified betulinic acid derivatives as antitumor agents

Cui, Hai-Wei,He, Yuan,Wang, Jinhua,Gao, Wei,Liu, Ting,Qin, Min,Wang, Xue,Gao, Cheng,Wang, Yan,Liu, Ming-Yao,Yi, Zhengfang,Qiu, Wen-Wei

, p. 240 - 248 (2015)

Abstract A series of novel heterocycle-modified betulinic acid (BA) derivatives were synthesized and investigated for their activity against the growth of eight non-drug resistant and one multidrug-resistant tumor cell line using a sulforhodamine B (SRB) assay. The most active compound 17 showed an average IC50 1.19 μM, which was about 20 times more potent than the lead compound BA. It is amazing that for most synthetic saturated N-heterocycle derivatives, MCF-7/ADR was the most sensitive tumor cells, especially 17 showed the most potent antitumor activity (IC50 = 0.33 μM) on this multidrug-resistant tumor cell line, that was 117 times more potent than BA. Most of the tested compounds displayed less toxic on human fibroblasts (HAF) in comparison with the tumor cell lines. The cytometry and transwell migration assays were used to test the ability of 17 to induce apoptosis and inhibit metastasis on tumor cell lines respectively.

Novel Betulinic Acid-Nucleoside Hybrids with Potent Anti-HIV Activity

Wang, Qiang,Li, Yujiang,Zheng, Liyun,Huang, Xiaowan,Wang, Yanli,Chen, Chin-Ho,Cheng, Yung-Yi,Morris-Natschke, Susan L.,Lee, Kuo-Hsiung

, p. 2290 - 2293 (2020)

Novel betulinic/betulonic acid-nucleoside hybrids were synthesized as possible new anti-HIV agents. Among the synthesized hybrids, two compounds were highly effective against HIV. Compared with AZT and DSB, compounds 10a (IC50= 0.0078 μM, CC50= 9.6 μM) and 10b (IC50= 0.020 μM, CC50= 23.8 μM) showed more potent or equipotent, respectively, anti-HIV activity but displayed lower cytotoxicity.

Optimization of invasion-specific effects of betulin derivatives on prostate cancer cells through lead development

H?rm?, Ville,Haavikko, Raisa,Virtanen, Johannes,Ahonen, Ilmari,Schukov, Hannu-Pekka,Alakurtti, Sami,Purev, Enkhee,Rischer, Heiko,Yli-Kauhaluoma, Jari,Moreira, Vania M.,Nees, Matthias,Oksman-Caldentey, Kirsi-Marja

, (2015)

The anti-invasive and anti-proliferative effects of betulins and abietane derivatives was systematically tested using an organotypic model system of advanced, castration-resistant prostate cancers. A preliminary screen of the initial set of 93 compounds was performed in two-dimensional (2D) growth conditions using non-transformed prostate epithelial cells (EP156T), an androgen-sensitive prostate cancer cell line (LNCaP), and the castration-resistant, highly invasive cell line PC-3. The 25 most promising compounds were all betulin derivatives. These were selected for a focused secondary screen in three-dimensional (3D) growth conditions, with the goal to identify the most effective and specific anti-invasive compounds. Additional sensitivity and cytotoxicity tests were then performed using an extended cell line panel. The effects of these compounds on cell cycle progression, mitosis, proliferation and unspecific cytotoxicity, versus their ability to specifically interfere with cell motility and tumor cell invasion was addressed. To identify potential mechanisms of action and likely compound targets, multiplex profiling of compound effects on a panel of 43 human protein kinases was performed. These target de-convolution studies, combined with the phenotypic analyses of multicellular organoids in 3D models, revealed specific inhibition of AKT signaling linked to effects on the organization of the actin cytoskeleton as the most likely driver of altered cell morphology and motility.

Synthesis and anti-HCV entry activity studies of β-cyclodextrin- pentacyclic triterpene conjugates

Xiao, Sulong,Wang, Qi,Si, Longlong,Shi, Yongying,Wang, Han,Yu, Fei,Zhang, Yongmin,Li, Yingbo,Zheng, Yongxiang,Zhang, Chuanling,Wang, Chunguang,Zhang, Lihe,Zhou, Demin

, p. 1060 - 1070 (2014)

In our previous studies, oleanolic acid (OA) and echinocystic acid (EA), isolated from Dipsacus asperoides, were found to have anti-HCV entry properties. The major issue for members of this type of triterpene is their low water solubility. In this study, a series of new water-soluble triazole-bridged β-cyclodextrin (CD)-pentacyclic triterpene conjugates were synthesized via click chemistry. Thanks to the attached β-CD moiety, all synthesized conjugates showed lower hydrophobicity (Alog P) than their parent compounds. Several conjugates exhibited moderate anti-HCV entry activity. With the exception of per-O-methylated β-CD-pentacyclic triterpene conjugates, all other conjugates showed no cytotoxicity based on an alamarBlue assay carried out with HeLa, HepG2, MDCK, and 293T cells. More interestingly, the hemolytic activity of these conjugates disappeared upon the introduction of β-CDs. Easy access to such conjugates that combine the properties of β-CD and pentacyclic triterpenes may provide a way to obtain a new class of anti-HCV entry inhibitors. An awesome CD collection: A series of water-soluble triazole-bridged β-cyclodextrin (CD)-pentacyclic triterpene conjugates were synthesized, and their hydrophobicity, anti-HCV entry activities, and toxicity were studied. Easy access to such conjugates may provide a way to obtain a new class of anti-HCV entry inhibitors.

Rhodamine B-based fluorescent probes for molecular mechanism study of the anti-influenza activity of pentacyclic triterpenes

Chen, Yingying,Li, Man,Ma, Wenxiao,Ran, Fuxiang,Xiao, Sulong,Yuan, Lan,Zhang, Lihe,Zhou, Demin

, (2020)

The antiviral activity of pentacyclic triterpenes has attracted increasing attention. However, the detailed antiviral mechanism remains fully unclear. In the present study, four C28 or C30 modified pentacyclic triterpene probes via conjugating with rhodamine B were designed and synthesized, and their anti-influenza virus activity was evaluated. The results indicated that two compounds 14 and 23 showed significant antiviral activity to influenza A/WSN/33 (H1N1) virus in Madin-Darby canine kidney (MDCK) cells with IC50 values of 8.36 and 8.24 μM, respectively. The mechanism of action studies of representative probe 23 indicated that it could inhibit the membrane fusion by binding with influenza virus hemagglutinin (HA), and the apparent dissociation constant (KD) value for probe 23-HA interaction was successfully evaluated (1.78 × 10?5 M) using surface plasmon resonance spectroscopy. In addition, the subcellular localization of probe 23 in MDCK cells was determined by confocal microscopy and flow cytometry, and the results suggested that fluorescent probe 23 was rapidly taken up in MDCK cells and accumulated in cytoplasm, but no antiviral activity was observed after its entry into cells. The present study further confirmed our previous finding that pentacyclic triterpenes could tightly bind to the viral envelope HA protein, thus blocking the virus entry into host cells.

Lupane triterpenes and derivatives with antiviral activity

Baltina,Flekhter,Nigmatullina,Boreko,Pavlova,Nikolaeva,Savinova,Tolstikov

, p. 3549 - 3552 (2003)

Betulin and betulinic acid have been modified at the C-3 and C-28 positions and the antiviral activity of derivatives has been evaluated in vitro. It was found that simple modifications of the parent structure of lupane triterpenes produced highly effective agents against influenza A and herpes simplex type 1 viruses.

Biotransformation of betulinic and betulonic acids by fungi

Bastos, Denise Z.L.,Pimentel, Ida C.,de Jesus, Daniel A.,de Oliveira, Bras H.

, p. 834 - 839 (2007)

Betulinic acid (1), a triterpenoid found in many plant species, has attracted attention due to its important pharmacological properties, such as anti-cancer and anti-HIV activities. The closely related, betulonic acid (2) also has similar properties. In order to obtain derivatives potentially useful for detailed pharmacological studies, both compounds were submitted to incubations with selected microorganisms. In this work, both were individually metabolized by the fungi Arthrobotrys, Chaetophoma and Dematium, isolated from the bark of Platanus orientalis as well as with Colletotrichum, obtained from corn leaves; such fungal transformations are quite rare in the scientific literature. Biotransformations with Arthrobotrys converted betulonic acid (2) into 3-oxo-7β-hydroxylup-20(29)-en-28-oic acid (3), 3-oxo-7β,15α-dihydroxylup-20(29)-en-28-oic acid (4) and 3-oxo-7β,30-dihydroxylup-20(29)-en-28-oic acid (5); Colletotrichum converted betulinic acid (1) into 3-oxo-15α-hydroxylup-20(29)-en-28-oic (6) acid whereas betulonic acid (2) was converted into the same product and 3-oxo-7β,15α-dihydroxylup-20(29)-en-28-oic acid (4); Chaetophoma converted betulonic acid (2) into 3-oxo-25-hydroxylup-20(29)-en-28-oic acid (7) and both Chaetophoma and Dematium converted betulinic acid (1) into betulonic acid (2). Those fungi, therefore, are useful for mild, selective oxidations of lupane substrates at positions C-3, C-7, C-15, C-25 and C-30.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 4481-62-3